Humans

Brunetti, V. C., St-Jean, A., Dell'Aniello, S., Fisher, A., H. Y. Yu, O., Bugden, S. C., et al. (2022). Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom. Bmc Endocr Disord, 22, 241. http://doi.org/10.1186/s12902-022-01140-1
View
Pufulete, M., Harris, J., Pouwels, K., Reeves, B. C., Lasserson, D., Loke, Y. K., et al. (2022). Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England. Open Heart, 9. http://doi.org/10.1136/openhrt-2022-001999
View
Idris, I., Zhang, R., Mamza, J. B., Ford, M., Morris, T., Banerjee, A., & Khunti, K. (2021). Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease. Diabetes Obes Metab, 23, 2207-2214. http://doi.org/10.1111/dom.14437
View
Whittaker, H., Van Ganse, E., Dalon, F., Nolin, M., Marrant-Micallef, C., Pison, C., et al. (2022). Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. Bmj Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2021-001150
View
Suissa, S., Dell'Aniello, S., & Ernst, P. (2022). Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety. Int J Chron Obstruct Pulmon Dis, 17, 1975-1986. http://doi.org/10.2147/copd.s378486
View
Subramanian, A., Lee, S. I., Phillips, K., Toulis, K. A., Kempegowda, P., O'Reilly, M. W., et al. (2022). Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England. Bmc Med, 20, 298. http://doi.org/10.1186/s12916-022-02473-3
View
Simms-Williams, N., Nagakumar, P., Thayakaran, R., Adderley, N., Hotham, R., Mansur, A., et al. (2022). Preventing unscheduled hospitalisations from asthma: a retrospective cohort study using routine primary and secondary care data in the UK (The PUSH-Asthma Study)-protocol paper. Bmj Open, 12, e058356. http://doi.org/10.1136/bmjopen-2021-058356
View
Schmidt, J. C. F., Lambert, P. C., Gillies, C. L., & Sweeting, M. J. (2022). Patterns of rates of mortality in the Clinical Practice Research Datalink. Plos One, 17, e0265709. http://doi.org/10.1371/journal.pone.0265709
View
Requena, G., Banks, V., Czira, A., Wood, R., Tritton, T., Wild, R., et al. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781-1795. http://doi.org/10.2147/copd.s365480
View
Rebordosa, C., Plana, E., Rubino, A., Aguado, J., Martinez, D., Lei, A., et al. (2022). Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. Int J Chron Obstruct Pulmon Dis, 17, 1715-1733. http://doi.org/10.2147/copd.s363997
View